Old Web
English
Sign In
Acemap
>
authorDetail
>
Hiral A. Shah
Hiral A. Shah
University of Illinois at Chicago
Medicine
Pathology
Cancer research
Alisertib
Pazopanib
5
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Association of Population Screening for Breast Cancer Risk With Use of Mammography Among Women in Medically Underserved Racial and Ethnic Minority Groups.
2021
Candice Schwartz
Ifeanyi Beverly Chukwudozie
Silvia Tejeda
Ganga Vijayasiri
Ivy Abraham
Mylene Hernandez Remo
Hiral A. Shah
María Rojas
Alicia Carillo
Loraine Moreno
Richard B. Warnecke
Kent Hoskins
Show All
Source
Cite
Save
Citations (1)
A pilot study of Bruton’s tyrosine kinase inhibitor ibrutinib alone and in combination with PD-1 inhibitor nivolumab in patients with metastatic solid tumors.
2020
Journal of Clinical Oncology
Brooke Benner
Dionisia Marie Quiroga
Logan Good
Steven Sun
Himanshu Savardekar
Megan C. Duggan
Bhavana Konda
Claire F. Verschraegen
Kari Kendra
Manisha H. Shah
Robert Rupert
Paul Monk
Hiral A. Shah
Anne M. Noonan
Kristin Bixel
John L. Hays
Gregory K. Behbehani
Maciej Pietrzak
William E. Carson
Robert Wesolowski
Show All
Source
Cite
Save
Citations (3)
Re-evaluating the neutrophil-to-lymphocyte ratio: Machine learning-based variable selection for predicting survival at twelve months in late-stage cancer patients receiving immunotherapy.
2019
Journal of Clinical Oncology
Daniel Spakowicz
Mingjia Li
Rebecca Hoyd
Jarred Thomas Burkart
Sandip H. Patel
Marium Husain
Kai He
Carolyn J. Presley
Erin M. Bertino
Peter G. Shields
David P. Carbone
Hiral A. Shah
Gabriel Tinoco
Edmund Folefac
Priyanka Bhateja
Claire F. Verschraegen
Gregory A. Otterson
Lang Li
Kari Kendra
Dwight Hall Owen
Show All
Source
Cite
Save
Citations (0)
Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors
2019
American Journal of Clinical Oncology
Hiral A. Shah
James H. Fischer
Neeta K. Venepalli
Oana Cristina Danciu
Sonia Christian
Meredith J. Russell
Li C. Liu
James P. Zacny
Arkadiusz Z. Dudek
Show All
Source
Cite
Save
Citations (0)
STM-01: Phase I EFFTox study of aurora A kinase inhibitor alisertib (MLN8237) given in combination with selective VEGFR inhibitor pazopanib for therapy of solid tumors.
2015
Journal of Clinical Oncology
Hiral A. Shah
Sonia Christian
Bilawal Ahmed
Rozina A. Chowdhery
Neeta K. Venepalli
Oana Cristina Danciu
Arkadiusz Z. Dudek
Show All
Source
Cite
Save
Citations (2)
1